Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
Francine Garnache‐Ottou, Jean Feuillard, Christophe Ferrand, et al.
British Journal of Haematology (2009) Vol. 145, Iss. 5, pp. 624-636
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
Jacques J. M. van Dongen, Ludovic Lhermitte, Sebastian Böttcher, et al.
Leukemia (2012) Vol. 26, Iss. 9, pp. 1908-1975
Open Access | Times Cited: 845
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Haematologica (2012) Vol. 98, Iss. 2, pp. 239-246
Open Access | Times Cited: 304
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, et al.
Blood (2020) Vol. 137, Iss. 6, pp. 751-762
Open Access | Times Cited: 260
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Ugo Testa, Elvira Pelosi, Arthur E. Frankel
Biomarker Research (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 230
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
Arthur E. Frankel, Jung Hee Woo, Chul Ahn, et al.
Blood (2014) Vol. 124, Iss. 3, pp. 385-392
Open Access | Times Cited: 215
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 177
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
Marie C. Béné, Thomas Nebe, Peter Bettelheim, et al.
Leukemia (2011) Vol. 25, Iss. 4, pp. 567-574
Closed Access | Times Cited: 210
Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients
Carlo Cota, Esmeralda Vale, Isabel Viana, et al.
The American Journal of Surgical Pathology (2009) Vol. 34, Iss. 1, pp. 75-87
Closed Access | Times Cited: 197
Plasmacytoid Dendritic Cells
Armin G. Jegalian, Fabio Facchetti, Elaine S. Jaffe
Advances in Anatomic Pathology (2009) Vol. 16, Iss. 6, pp. 392-404
Open Access | Times Cited: 181
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
Damien Roos‐Weil, Sascha Dietrich, Ariane Boumendil, et al.
Blood (2012) Vol. 121, Iss. 3, pp. 440-446
Open Access | Times Cited: 159
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
Armin G. Jegalian, Nataliya P. Buxbaum, Fabio Facchetti, et al.
Haematologica (2010) Vol. 95, Iss. 11, pp. 1873-1879
Open Access | Times Cited: 159
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli, Zhiying Esther Hou, Priscilla N. Kelly, et al.
Cancer Cell (2016) Vol. 30, Iss. 5, pp. 764-778
Open Access | Times Cited: 143
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
Khaled Alayed, Keyur P. Patel, Sergej Konoplev, et al.
American Journal of Hematology (2013) Vol. 88, Iss. 12, pp. 1055-1061
Open Access | Times Cited: 133
Blastic Plasmacytoid Dendritic Cell Neoplasms
Fanny Julia, Stéphane Dalle, Gérard Duru, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 5, pp. 673-680
Closed Access | Times Cited: 129
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
Tomohiro Aoki, Ritsuro Suzuki, Yachiyo Kuwatsuka, et al.
Blood (2015) Vol. 125, Iss. 23, pp. 3559-3562
Open Access | Times Cited: 124
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Extramedullary Manifestations of Myeloid Neoplasms
Carla S. Wilson, L. Jeffrey Medeiros
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 2, pp. 219-239
Open Access | Times Cited: 109
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martín‐Martín, Antonio López, María‐Belén Vidriales, et al.
Oncotarget (2015) Vol. 6, Iss. 22, pp. 19204-19216
Open Access | Times Cited: 107
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group
Nikolaos J. Tsagarakis, Nektaria Kentrou, Konstantinos A. Papadimitriou, et al.
Leukemia Research (2009) Vol. 34, Iss. 4, pp. 438-446
Closed Access | Times Cited: 102
Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity
Sascha Dietrich, Mindaugas Andrulis, Ute Hegenbart, et al.
Biology of Blood and Marrow Transplantation (2011) Vol. 17, Iss. 8, pp. 1250-1254
Closed Access | Times Cited: 86
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review
Michael J. Rauh, Fazlur Rahman, David Good, et al.
Leukemia Research (2011) Vol. 36, Iss. 1, pp. 81-86
Closed Access | Times Cited: 86
Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
Wasif Riaz, Ling Zhang, Pedro Horna, et al.
Cancer Control (2014) Vol. 21, Iss. 4, pp. 279-289
Open Access | Times Cited: 81
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan‐Dabaja, Hillard M. Lazarus, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation (2013) Vol. 19, Iss. 7, pp. 1006-1012
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top